CSL Ltd. (CMXHF)
120.00
0.00 (0.00%)
USD |
OTCM |
Aug 26, 16:00
CSL Price : 120.00 for Aug. 26, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Aug 26, 2026 | 120.00 | 120.00 | 120.00 | 120.00 | 12840.00 |
| Aug 25, 2026 | 120.00 | 120.00 | 120.00 | 120.00 | 7500.00 |
| Aug 24, 2026 | 120.00 | 120.00 | 120.00 | 120.00 | 0.000 |
| Aug 21, 2026 | 120.00 | 120.00 | 120.00 | 120.00 | 0.000 |
| Aug 20, 2026 | 120.00 | 120.00 | 120.00 | 120.00 | 704.00 |
| Aug 19, 2026 | 118.69 | 118.69 | 118.69 | 118.69 | 7915.00 |
| Aug 18, 2026 | 109.00 | 111.28 | 109.00 | 111.28 | 170.00 |
| Aug 17, 2026 | 98.03 | 98.03 | 98.03 | 98.03 | 0.000 |
| Aug 14, 2026 | 98.03 | 98.03 | 98.03 | 98.03 | 932.00 |
| Aug 13, 2026 | 98.03 | 98.03 | 98.03 | 98.03 | 0.000 |
| Aug 12, 2026 | 97.92 | 98.03 | 97.92 | 98.03 | 11.00 |
| Aug 11, 2026 | 98.58 | 99.86 | 96.20 | 96.20 | 670.00 |
| Aug 10, 2026 | 92.38 | 93.67 | 92.38 | 93.67 | 85.00 |
| Aug 07, 2026 | 91.62 | 91.62 | 91.62 | 91.62 | 17502.00 |
| Aug 06, 2026 | 93.40 | 93.40 | 93.40 | 93.40 | 777.00 |
| Aug 05, 2026 | 90.28 | 90.28 | 90.28 | 90.28 | 0.000 |
| Aug 04, 2026 | 89.52 | 92.88 | 89.52 | 90.28 | 228.00 |
| Aug 03, 2026 | 87.78 | 87.78 | 87.78 | 87.78 | 7.000 |
| Jul 31, 2026 | 87.86 | 87.86 | 87.86 | 87.86 | 14082.00 |
| Jul 30, 2026 | 88.94 | 88.94 | 88.94 | 88.94 | 0.000 |
| Jul 29, 2026 | 89.01 | 89.01 | 88.94 | 88.94 | 212.00 |
| Jul 28, 2026 | 79.99 | 79.99 | 79.99 | 79.99 | 458.00 |
| Jul 27, 2026 | 79.24 | 79.99 | 79.24 | 79.99 | 151.00 |
| Jul 24, 2026 | 81.96 | 81.96 | 81.96 | 81.96 | 738.00 |
| Jul 23, 2026 | 81.96 | 81.96 | 81.96 | 81.96 | 0.000 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Immutep Ltd. | 0.3798 |
| Ceryvyn Therapeutics Ltd. | 0.0232 |
| Propanc Biopharma, Inc. | 2.37 |
| Mesoblast Ltd. | 18.02 |
| Actinogen Medical Ltd. | 0.035 |
Price Related Metrics
| PS Ratio | 3.688 |
| Price to Free Cash Flow | 25.91 |
| Earnings Yield | -4.50% |
| Market Cap | 57.47B |
| Operating PE Ratio | 14.48 |
| Normalized PE Ratio | 20.24 |